CMPI insider transactions
Checkmate Pharmaceuticals Inc. (CMPI) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for CMPI
- SEC Form 4 filed by Powell Michael4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4 filed by Flaherty Keith T.4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4 filed by Isacoff Oren4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4 filed by Colabuono Peter4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4 filed by Yan Joy4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4 filed by Dolski Robert4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4 filed by Wooldridge James4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4 filed by Wigginton Jon Marc4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4 filed by Fuhrman Alan4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4 filed by Bash Alan4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4: Venbio Global Strategic Fund Ii L.P. sold $1,375,564 worth of shares (131,650 units at $10.45)4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4: Venbio Global Strategic Fund Ii L.P. sold $1,671,824 worth of shares (160,901 units at $10.39)4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4: Venbio Global Strategic Fund Ii L.P. sold $898,921 worth of shares (86,677 units at $10.37)4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4: Venbio Global Strategic Fund Ii L.P. sold $2,809,332 worth of shares (270,675 units at $10.38)4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4: Venbio Global Strategic Fund Ii L.P. sold $1,972,579 worth of shares (190,026 units at $10.38)4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4 filed by Wooldridge James4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4: Venbio Global Strategic Fund Ii L.P. sold $1,347,796 worth of shares (129,781 units at $10.39)4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4: Venbio Global Strategic Fund Ii L.P. sold $5,700,491 worth of shares (547,734 units at $10.41)4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4 filed by Bash Alan4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 3 filed by new insider Bash Alan3 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4 filed by Wigginton Jon Marc4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 3 filed by new insider Wigginton Jon Marc3 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4 filed by Dolski Robert4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4 filed by Wooldridge James4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4 filed by Yan Joy4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 3 filed by new insider Yan Joy3 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4 filed by Fuhrman Alan4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4 filed by POWELL MICHAEL4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4 filed by Wooldridge James4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4 filed by Chaudhary Kleem4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4 filed by Dolski Robert4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4 filed by Labinger Barry4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4 filed by Flaherty Keith T.4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4 filed by Fuhrman Alan4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4 filed by Isacoff Oren4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4 filed by Colabuono Peter4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4 filed by POWELL MICHAEL4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4: Krieg Arthur M bought $43,633 worth of Common Stock (7,224 units at $6.04), increasing direct ownership by 0.89% to 815,734 units4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4: Krieg Arthur M bought $22,112 worth of Common Stock (3,578 units at $6.18), increasing direct ownership by 0.44% to 808,510 units4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4 filed by Krieg Arthur M4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4: M Arthur Krieg bought $370,673 worth of Common Stock (33,220 units at $11.16), increasing direct ownership by 4% to 779,931 units4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4: M Arthur Krieg bought $166,275 worth of Common Stock (13,520 units at $12.30), increasing direct ownership by 2% to 746,711 units4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4: Kleem Chaudhary exercised 2,000 units of Common Stock at a strike of $2.62, increasing ownership by 33% to 8,000 units4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4: M Arthur Krieg bought $22,198 worth of Common Stock (1,701 units at $13.05), increasing ownership by 0.23% to 733,191 units4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)
- SEC Form 4: M Arthur Krieg bought $6,545 worth of Common Stock (500 units at $13.09), increasing ownership by 0.07% to 731,490 units4 - Checkmate Pharmaceuticals, Inc. (0001651431) (Issuer)